6751 - 6775 of 9038 Results
Title
Year
-
OPENTitle: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 InhibitionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 760End Page: 773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27994Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8167931Citation Count: 108
- GBA variation and susceptibility to multiple system atrophy2020RESTRICTEDTitle: GBA variation and susceptibility to multiple system atrophyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 64End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.007Citation Count: 26
-
OPENTitle: Hemispheric lateralization of dopamine transporter binding in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 141Issue #:Start Page: 108076End Page: 108076Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108076Best OA location URL: https://doi.org/10.1016/j.parkreldis.2025.108076Citation Count: 0
-
OPENTitle: NeuroBooster Array: A Genome‐Wide Genotyping Platform to Study Neurological Disorders Across Diverse PopulationsJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 11Start Page: 2039End Page: 2048Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29902Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29902Citation Count: 38
- Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril Binding2019RESTRICTEDTitle: Pyridine-Fused 2-Pyridones via Povarov and A3 Reactions: Rapid Generation of Highly Functionalized Tricyclic Heterocycles Capable of Amyloid Fibril BindingJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 84Issue #: 7Start Page: 3887End Page: 3903Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.joc.8b03015Citation Count: 22
-
OPENTitle: Pooled analysis of iron-related genes in Parkinson's disease: Association with transferrinJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 62Issue #:Start Page: 172End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2013.09.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0969996113002659Citation Count: 87
-
OPENTitle: Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 QuantificationJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 13Issue #: 10Start Page: 1606End Page: 1614Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.2c00278Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9575163Citation Count: 4
- Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease2020RESTRICTEDTitle: Ondansetron, a highly selective 5-HT3 receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseJournal Name: European Journal of PharmacologyPublisher: Elsevier BVVol: 871Issue #:Start Page: 172914End Page: 172914Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejphar.2020.172914Citation Count: 21
-
OPENTitle: Prevalence and Risk Factors for Double Vision in Parkinson DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 709End Page: 712Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13220Citation Count: 12
- A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's Disease2016RESTRICTEDTitle: A Phase 2A Trial of the Novel mGluR5‐Negative Allosteric Modulator Dipraglurant for Levodopa‐Induced Dyskinesia in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 9Start Page: 1373End Page: 1380Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26659Citation Count: 140
-
OPENTitle: Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2539End Page: 2548Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28533Citation Count: 60
- Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's Disease2025OPENTitle: Association between Perceived Dysphagia Symptoms and Swallowing Physiology in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 10Start Page: 1571End Page: 1581Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.70129Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.70129Citation Count: 4
- Lewy bodies are incidental in essential tremor2016RESTRICTEDTitle: Lewy bodies are incidental in essential tremorJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 26Issue #:Start Page: 81End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2016.02.025Citation Count: 3
-
OPENTitle: Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonismJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12974-026-03716-3Best OA location URL: https://doi.org/10.1186/s12974-026-03716-3Citation Count: 1
- Total-Body Irradiation Alters White Matter Volume and Microstructural Integrity in Rhesus Macaques2023RESTRICTEDTitle: Total-Body Irradiation Alters White Matter Volume and Microstructural Integrity in Rhesus MacaquesJournal Name: International Journal of Radiation Oncology*Biology*PhysicsPublisher: Elsevier BVVol: 119Issue #: 1Start Page: 208End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.ijrobp.2023.11.014Citation Count: 5
-
OPENTitle: Parkinson's disease progression is shaped by longitudinal changes in cerebral compensationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 149Issue #: 1Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaf302Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf302/64029765/awaf302.pdfCitation Count: 5
-
OPENTitle: Olfactory Bulb Amyloid-β Correlates With Brain Thal Amyloid Phase and Severity of Cognitive ImpairmentJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 81Issue #: 8Start Page: 643End Page: 649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlac042Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9297096Citation Count: 15
- Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum2018RESTRICTEDTitle: Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 236Issue #: 4Start Page: 955End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-018-5191-9Citation Count: 19
-
OPENTitle: Exploring the Interactions between two Ligands, UCB-J and UCB-F, and Synaptic Vesicle Glycoprotein 2 IsoformsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 10Start Page: 2018End Page: 2027Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00029Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00029Citation Count: 1
-
OPENTitle: Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 357Issue #: 6357Start Page: 1255End Page: 1261Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.aam9080Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6021018Citation Count: 862
- α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance Disorders2021OPENTitle: α4β2 * Nicotinic Cholinergic Receptor Target Engagement in Parkinson Disease Gait–Balance DisordersJournal Name: Annals of NeurologyPublisher: WileyVol: 90Issue #: 1Start Page: 130End Page: 142Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26102Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.26102Citation Count: 25
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic FailureJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 6Start Page: 1212End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8168720Citation Count: 104
-
OPENTitle: Predicting alpha-synuclein pathology by REM sleep behavior disorder diagnosisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 55Issue #:Start Page: 92End Page: 96Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.05.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7850633Citation Count: 28
- Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's Disease2019RESTRICTEDTitle: Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 3Start Page: 457End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27928Citation Count: 58
- Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s disease2019RESTRICTEDTitle: Assessment of plasma creatine kinase as biomarker for levodopa-induced dyskinesia in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 126Issue #: 6Start Page: 789End Page: 793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-019-02015-xCitation Count: 3